Date  |
|
| Feb 14, 2019 |
CEL-SCI Corporation Reports First Quarter Fiscal 2019 Financial Results |
| Feb 7, 2019 |
CEL-SCI to Present at 2019 BIO CEO & Investor Conference |
| Jan 23, 2019 |
U.S. Patent Office Issues CEL-SCI Two Patents for Its LEAPS Vaccine Platform Technology |
| Jan 15, 2019 |
CEL-SCI Regains Full Listing Compliance with NYSE American |
| Dec 20, 2018 |
CEL-SCI Reports Fiscal 2018 Financial Results and Clinical & Corporate Developments |
| Oct 23, 2018 |
CEL-SCI Receives about $8 Million from Warrant Exercises |
| Sep 28, 2018 |
CEL-SCI Announces Warrants to Expire on October 11, 2018 |
| Sep 14, 2018 |
CEL-SCI Receives $5.4 Million from Warrant Exercises |
| Sep 5, 2018 |
NIH Selects CEL-SCI’s LEAPS Rheumatoid Arthritis Vaccine for Commercialization Accelerator Program |
| Aug 21, 2018 |
CEL-SCI Corporation Releases Letter to Shareholders |